Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

3.23
Delayed Data
As of Jul 02
 -0.02 / -0.62%
Today’s Change
1.00
Today|||52-Week Range
8.46
+26.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues2.0M854.0K896.0K854.0K
 
 
 
 
 
Depreciation And Amortization6.0K7.0K11.0K11.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses13.6M14.2M12.0M9.6M
 
 
 
 
 
Research And Development7.2M6.9M6.0M4.5M
 
 
 
 
 
Total Operating Expenses13.6M14.2M12.1M9.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.6M-13.3M-11.2M-8.8M
 
 
 
 
 
Extraordinary Credit333.0K0.00--0.00
 
 
Extraordinary Charge0.00-1.6M---89.0K
 
 
 
Interest Expense On Debt470.0K391.0K311.0K239.0K
 
 
 
 
 
Other Expenses-40.0K11.0K10.1M-31.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.8M-15.3M-1.3M-9.1M
 
 
 
 
 
Net Income-11.8M-15.3M-1.3M-9.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.2M60.5M63.0M67.6M
 
 
 
 
 
Shares To Calculate EPS Diluted61.9M60.5M63.0M67.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.25-$0.02-$0.13
 
 
 
 
 
EPS Diluted-$0.20-$0.25-$0.02-$0.13
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account